Assistant Professor, Medicine, University of Colorado School of Medicine
Oncology
Dr. Jonathan A. Gutman, MD
|
|
Give Review
Jonathan Gutman practices Oncology. He went to medical school at NYU School of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Jonathan A. Gutman, MD is a published doctor. He published 30 publications, including: 'Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.' Jonathan Gutman accepts Medicare.
Publications
- Clonality of neutrophilia associated with plasma Cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.
- Stopping Higher-Risk Myelodysplastic Syndrome in Its Tracks.
- Antithrombotic Therapy in Patients With Thrombocytopenic Cancer: Outcomes Associated With Reduced-Dose, Low-Molecular-Weight Heparin During Hospitalization.
- Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute ...
- Adjusting DLCO for Hb and its effects on the Hematopoietic Cell Transplantation-specific Comorbidity Index.
- Omacetaxine mepesuccinate for the treatment of chronic myeloid Leukemia.
- Ponatinib for the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive Acute lymphoblastic leukemia.
- A Novel CEBPA Germline Variant in a Case of Acute Myeloid Leukemia.
- Intensive strategy to prevent cytomegalovirus Disease in seropositive umbilical cord blood transplant recipients.
- Cord blood collection after cesarean section improves banking efficiency.
- Stable Long-Term Pulmonary Function after Myeloablative Double Cord Blood Transplant.
- Allogeneic hematopoietic Cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.
- Double unit cord blood transplantation: Who wins-and why do we care?
- Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonenGrafted unit.
- Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for Acute leukemia in complete remission: a matched cohor...
- Optic nerve sheath diameter correlates with the presence and severity of Acute mountain sickness: evidence for increased intracranial pressure.
- Prospective monitoring for alloimmunization in cord blood transplantation: "virtual crossmatch" can be used to demonstrate donor-directed antibodies.
- Chest ultrasonography for the diagnosis and monitoring of high-altitude pulmonary edema.
- Treatment of high altitude pulmonary edema at 4240 m in Nepal.
- New-onset anxiety Disorders at high altitude.
- Evidence for increased intracranial pressure in high altitude pulmonary edema.
- Arterial thrombosis at high altitude resulting in loss of limb.
- A 50-year-old man with skin lesions and multiple pulmonary nodules.
- Expansion of Human and Murine Hematopoietic Stem and Progenitor Cells Ex Vivo without Genetic Modification Using MYC and Bcl-2 Fusion Proteins.
- Results of complete soft tissue clubfoot release combined with calcaneocuboid fusion in the 4-year to 8-year age group following failed clubfoot release.
- Rhinovirus as a cause of fatal lower respiratory tract infection in adult stem Cell transplantation patients: a report of two cases.
- Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced Lymphoma patients: a feasibility...
- Pulmonary veno-occlusive Disease following reduced-intensity cord blood transplantation.
- Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications.
Schools
New York University School Of Medicine
University Of Colorado University Hospital Program
Fred Hutchinson Cancer Research Center
University Of Washington Program
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Washington -
University of Colorado -
NYU School of Medicine
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1003882952 | |
| NPPES Provider LastName | GUTMAN | |
| NPPES Provider FirstName | JONATHAN | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 552.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003882952 |
| Last Name Of The Provider | GUTMAN |
| First Name Of The Provider | JONATHAN |
| View All |
Similar Doctors
|
Dr. Eamon M. Berge, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Anthony D. Elias, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert C. Doebele, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Virginia Borges, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Antonio Jimeno, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Wells A. Messersmith, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|